GlyPerA™ effectively shields airway epithelia from SARS-CoV-2 infection and inflammatory events
Description
New SARS-CoV-2 variants of concern (VOCs) and waning immunity illustrate that quick and easy-to-use agents are needed to prevent infection. To protect from viral transmission and subsequent inflammatory reactions, we applied GlyperA™, a novel
